About ALA Diagnostics
ALA Diagnostics is a company based in Madrid (Spain) founded in 2019 by Jose Ramon Montero. ALA Diagnostics has raised $1.2 million across 1 funding round from investors including BeAble Capital. ALA Diagnostics offers products and services including EM KIT and In Vitro Diagnostic Kits. ALA Diagnostics operates in a competitive market with competitors including ADx NeuroSciences, Cytox, Amprion, PeopleBio R&D and Durin Technologies, among others.
- Headquarter Madrid, Spain
- Founders Jose Ramon Montero
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.2 M (USD)
in 1 rounds
-
Latest Funding Round
$1.2 M (USD), Seed
Jun 22, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ALA Diagnostics
ALA Diagnostics offers a comprehensive portfolio of products and services, including EM KIT and In Vitro Diagnostic Kits.
Kit for early blood-based diagnosis of Multiple Sclerosis.
Kits for diagnosing high-prevalence pathologies through sample analysis.
Funding Insights of ALA Diagnostics
ALA Diagnostics has successfully raised a total of $1.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.2 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ALA Diagnostics
ALA Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BeAble Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early stage energy and tech focused VC firm investing primarily in Spain
|
Locked | Locked | Locked |
Investor details for ALA Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ALA Diagnostics
Investment portfolio details for ALA Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ALA Diagnostics
Detailed financials for ALA Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ala Diagnostics Comparisons
Peer comparison for ALA Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ALA Diagnostics
ALA Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ADx NeuroSciences, Cytox, Amprion, PeopleBio R&D and Durin Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| Locked | Locked | Locked |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Developer of the diagnostic test for neurodegenerative diseases
|
Detailed competitors of ALA Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ala Diagnostics
Complete news archive for ALA Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ALA Diagnostics
ALA Diagnostics was founded in 2019 and raised its 1st funding round 4 years after it was founded.
ALA Diagnostics is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
ALA Diagnostics is a funded company, having raised a total of $1.2M across 1 funding round to date.
ALA Diagnostics was founded in 2019 in Madrid, Spain, within the biotechnology sector. In vitro diagnostic kits for detecting multiple sclerosis are developed by the company. A blood test that utilizes a patented recombinant protein as a biomarker for multiple sclerosis is provided. Operations center on advancing diagnostic tools for neurological conditions, with a focus on accessible testing methods in Europe.
ALA Diagnostics's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.
ALA Diagnostics offers EM KIT and In Vitro Diagnostic Kits.
ALA Diagnostics has 1 investor. Key investors include BeAble Capital.